Diagnosing Childhood Diabetes: Why Telling Types Apart Matters More Than Ever

When a child is diagnosed with diabetes, the first question is often: which type? The answer shapes everything that comes next—from treatment plans to how families understand the condition and what to expect long-term. But getting there isn't always straightforward.

A new study from Seoul National University Children's Hospital examined 662 children diagnosed with diabetes over 20 years to understand how often each type occurs and what sets them apart. The researchers found that type 1 diabetes (T1D) was the most common, affecting about 72% of the group. Type 2 diabetes (T2D) accounted for roughly 22%, and a rare genetic form called MODY made up about 6%.

"Differentiating diabetes subtypes is essential for long-term management," the study notes—because overlapping symptoms can make it easy to misdiagnose.

Type 1 diabetes showed a distinctive profile: children with T1D were more likely to present with diabetic ketoacidosis (DKA), a serious condition where the body produces too many acids, and they were less likely to have a family history of diabetes.

Type 2 diabetes looked different. Children with T2D had higher body mass index (BMI) scores and were more often overweight or obese—factors closely linked to how T2D develops.

MODY, a rare genetic form, often runs strongly in families. The study identified genetic mutations in two genes most commonly: GCK and HNF1A. This genetic basis means family history is a key clue.

One striking finding: the proportion of children diagnosed with type 2 diabetes increased steadily over the 20 years studied, while MODY cases remained stable and type 1 stayed the largest group overall.

The reasons for this trend likely include rising rates of childhood obesity and weight gain globally—a known risk factor for type 2 diabetes. The study doesn't detail all the causes, but the pattern mirrors what researchers have observed in other countries.

The study highlights an important reality: correct diagnosis depends on more than clinical judgment. Autoantibody testing—blood tests that detect immune markers in type 1 diabetes—and genetic testing for MODY are crucial tools.

The researchers note that expanded insurance coverage for autoantibody testing and more affordable access to genetic sequencing have made accurate diagnosis more possible. This matters because without these tools, children can be misclassified, leading to wrong treatment paths.

Interestingly, the study found that 10 patients had their diabetes subtype reclassified during follow-up, and 3 children actually had features of both type 1 and MODY at the same time. This underscores that diagnosis isn't always final at first encounter—ongoing monitoring and updated information can lead to refinement.

Source: Annals of pediatric endocrinology & metabolism. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.